Daclizumab exhibits efficacy in multiple sclerosis subjects positive for interferon-beta neutralizing antibodies

被引：0
|
作者：
Neyer, Lauri [1 ]
Singer, Robert [1 ]
Wang, Helen [1 ]
Caras, Ingrid [1 ]
机构：
[1] PDL BioPharma, Preclin & Clin Dev Sci, Redwood City, CA USA
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S169 / S169
页数：1
相关论文
共 50 条
  • [31] Interferon-beta signal transduction, multiple sclerosis and auto-antibodies
    Gavasso, Sonia
    Skavland, Jorn
    Gjertsen, Bjorn Tore
    Myhr, Kjell-Morten
    Vedeler, Christian
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 134 - 135
  • [32] INTERFERON-BETA IN MULTIPLE-SCLEROSIS
    ARNASON, BGW
    NEUROLOGY, 1993, 43 (04) : 641 - 643
  • [33] INTERFERON-BETA AND MULTIPLE-SCLEROSIS
    CLANET, M
    REVUE NEUROLOGIQUE, 1993, 149 (8-9) : 443 - 444
  • [34] The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta
    Rice, G
    ARCHIVES OF NEUROLOGY, 2001, 58 (08) : 1297 - 1298
  • [35] Effects of neutralizing antibodies to interferon beta in multiple sclerosis: a logical paradox
    Sorensen, Per Soelberg
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (02) : 131 - 132
  • [36] Clinical significance of neutralizing antibodies to interferon beta in patients with Multiple Sclerosis
    Zarkesh-Esfahani, Sayyed Hamid
    Zare, Nasrin
    Gharagozloo, Marjan
    Shaygannejad, Vahid
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [37] Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: A comparison of three methods in a large Australasian cohort
    McKay, F
    Schibeci, S
    Heard, R
    Stewart, G
    Booth, D
    JOURNAL OF IMMUNOLOGICAL METHODS, 2006, 310 (1-2) : 20 - 29
  • [38] Deficient Phosphorylation of Stat1 in Leukocytes Identifies Neutralizing Antibodies in Multiple Sclerosis Patients Treated with Interferon-Beta
    Gavasso, Sonia
    Mosleth, Ellen Faergestad
    Maroy, Tove
    Jorgensen, Katarina
    Nakkestad, Hanne-Linda
    Gjertsen, Bjorn-Tore
    Myhr, Kjell-Morten
    Vedeler, Christian
    PLOS ONE, 2014, 9 (02):
  • [39] Preparation-specific genetically determined risk of developing neutralizing antibodies towards interferon-beta in patients with multiple sclerosis
    Link, J.
    Fink, K.
    Lundkvist, M.
    Brynedal, B.
    Kockum, I.
    Fogdell-Hahn, A.
    Hillert, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 361 - 361
  • [40] Cell-Based Reporter Gene Assay for Therapy-Induced Neutralizing Antibodies to Interferon-Beta in Multiple Sclerosis
    Martins, Thomas B.
    Rose, John W.
    Gardiner, Gareth L.
    Kusukawa, Noriko
    Husebye, Dee
    Hill, Harry R.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2013, 33 (02): : 52 - 57
12345